Metastatic HER2-Low Carcinoma of the Breast
Metastatic HER2-low carcinoma of the breast is a newly recognized subset of breast cancer characterized by low HER2 expression. It represents a significant proportion of cases previously categorized as HER2-negative. Advances in treatment strategies have led to new targeted therapies, offering hope for improved patient outcomes. Understanding HER2-Low Breast Cancer HER2 (human epidermal growth factor